ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,505.73
0.47%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Adverum Biotechnologies Inc (ADVM) Share Price

ADVM Adverum Biotechnologies Inc

7.62
-0.47 (-5.81%)
15 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Adverum Biotechnologies Inc NASDAQ:ADVM NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.47 -5.81 7.62 7.18 8.61 8.09 7.60 8.07 156,375 04:00:01   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 3.6M -117.17M -1.1597 -6.57 769.83M
 Type  Size  Price  Time  Units 
 20 50,061 7.62 20:53:36 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ADVM News
11/06/202421:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/06/202421:16EDGAR2Form 8-K - Current report
11/06/202413:00GLOBEAdverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
28/05/202419:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/05/202421:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202421:10EDGAR2Form 8-K - Current report
09/05/202421:05GLOBEAdverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Period
Draw mode
Data Downloads for ADVM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Adverum Biotechnologies Inc Articles